Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Diamond

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1995
A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiencyJ Guevara-Aguirre, O Vasconez, V Martinez, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndromeM A Vaccarello, F B Diamond, J Guevara-Aguirre, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary resultsV Martinez, O Vasconez, A L Martinez, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3S E Gargosky, K F Wilson, P J Fielder, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteinsS E Gargosky, K F Wilson, P J Fielder, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1995
A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiencyJ Guevara-Aguirre, O Vasconez, V Martinez, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndromeM A Vaccarello, F B Diamond, J Guevara-Aguirre, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary resultsV Martinez, O Vasconez, A L Martinez, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3S E Gargosky, K F Wilson, P J Fielder, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteinsS E Gargosky, K F Wilson, P J Fielder, et al.
Pageof 4